Abstract
People who inject drugs (PWID) are disproportionately affected by COVID-19 but show lower vaccine uptake. This study at a Miami syringe service program (SSP) identified predictors of vaccination and service delivery preferences. Results showed a 65% uptake rate, with older age, having a primary provider, and perceived vaccine benefits as key predictors. Most participants (86%) preferred receiving vaccines at the SSP, highlighting the role of these programs in bridging the healthcare trust gap.
Introduction
The COVID-19 pandemic exacerbated existing health disparities for marginalized communities, particularly people who inject drugs (PWID). Despite a high burden of comorbidities and increased risk of severe illness, vaccine uptake in this population remains significantly lower than in the general public. Barriers include institutional mistrust, healthcare stigma, and competing survival priorities like housing instability. This study investigates the predictors of vaccine uptake and delivery preferences among PWID at a syringe service program (SSP) in Miami, Florida, to inform low-barrier public health interventions.
Methods
Researchers conducted a cross-sectional survey of 135 PWID at the IDEA Miami SSP between June 2022 and July 2023. The study utilized the Health Belief Model (HBM) to assess psychosocial drivers of health behavior across six domains: perceived susceptibility, severity, benefits, barriers, self-efficacy, and cues to action. Bivariate analysis and odds ratios were used to compare individuals who were "vaccinated or willing" against those who were "unvaccinated and unwilling."
Predictors of Vaccination
The study identified several demographic and health-related factors that significantly influenced vaccination status. Older age was a notable predictor ($p = 0.0136$), as was having a primary healthcare provider ($p = 0.0208$).
Beyond demographics, confidence in the US healthcare system (OR = 4.50) and the absence of vaccine misconceptions were critical. Within the HBM framework, "perceived benefit" was the only domain significantly associated with increased odds of vaccination. Participants who believed the vaccine reduced the risk of infection or hospitalization were 2.7 to 4.4 times more likely to be vaccinated.
Vaccine Uptake and Delivery Preferences
While 81% of the general US population had received at least one dose at the time of the study, only 65.2% of the study sample had done so. Interestingly, while many participants had received their vaccines at the SSP (44.3%), a vast majority (86%) expressed a preference for the SSP as their primary vaccination site over traditional pharmacies or clinics.
The preference for SSPs is rooted in trust; while only 34% of participants trusted the general healthcare system, 97% trusted the SSP staff. Motivations for vaccination were primarily centered on protecting personal health (65.9%) and the health of family and friends (50.0%).
Conclusion and Future Directions
SSPs serve as "islands of trust" for PWID, making them ideal locations for preventative care. To optimize vaccine uptake, programs should focus on emphasizing the benefits of vaccination, addressing misconceptions, and offering tangible incentives like gift cards. Expanding the "one-stop-shop" model of SSPs to include routine immunizations for Hepatitis A/B and influenza could significantly improve health outcomes for this underserved population.
Summary updated